文献速递肾移植

抗体介导排斥反应中移植肾细胞外基质损伤的蛋白质组学研究

Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.
PubMed 文献 · J Am Soc Nephrol · 2020-09-08

该研究对30例早期AMR、ACR或ATN的肾活检标本进行激光捕获显微切割的肾小球和肾小管间质蛋白质组学分析,发现AMR中基底膜和细胞外基质蛋白显著减少,LAMC1、NPHS1和PTPRO表达下降,而galectin-1和CTSV上调,提示早期ECM重塑可能成为新的治疗机会。

要点

  • AMR肾小球和肾小管间质中基底膜及ECM蛋白显著减少。
  • AMR肾小球中galectin-1上调,抗HLA I类抗体可增加CTSV和galectin-1表达与分泌。
  • 肾小管间质中GSTO1增加,TNFα处理的近端小管上皮细胞中亦增加。

核心结论

  • AMR早期即存在细胞外基质重塑,基底膜蛋白减少,可能为治疗提供新靶点。

研究设计与样本

  • 对30例因故肾活检标本(早期AMR、ACR或ATN)的激光捕获显微切割肾小球和肾小管间质进行无偏蛋白质组学分析。

主要发现

  • AMR vs ACR:2026个肾小球蛋白中107个、2399个肾小管间质蛋白中112个显著差异表达(P<0.05)。
  • AMR vs ATN:2026个肾小球蛋白中112个、2399个肾小管间质蛋白中181个显著失调(P<0.05)。
  • AMR中肾小球和肾小管间质基底膜及ECM蛋白显著减少,LAMC1、NPHS1和PTPRO表达下降。
  • AMR肾小球中galectin-1上调,抗HLA I类抗体增加人肾小球内皮细胞CTSV表达及galectin-1表达与分泌。
  • AMR肾小管间质中GSTO1显著增加,TNFα处理的近端小管上皮细胞中亦增加。

临床怎么用

  • 早期AMR评估可关注ECM重塑相关蛋白,但尚无临床推荐。

局限性

  • 样本量30例,为因故肾活检标本,结论需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibody-mediated rejection (AMR) accounts for >50% of kidney allograft loss. Donor-specific antibodies (DSA) against HLA and non-HLA antigens in the glomeruli and the tubulointerstitium cause AMR while inflammatory cytokines such as TNFα trigger graft injury. The mechanisms governing cell-specific injury in AMR remain unclear. METHODS: Unbiased proteomic analysis of laser-captured and microdissected glomeruli and tubulointerstitium was performed on 30 for-cause kidney biopsy specimens with early AMR, acute cellular rejection (ACR), or acute tubular necrosis (ATN). RESULTS: A total of 107 of 2026 glomerular and 112 of 2399 tubulointerstitial proteins was significantly differentially expressed in AMR versus ACR; 112 of 2026 glomerular and 181 of 2399 tubulointerstitial proteins were significantly dysregulated in AMR versus ATN (P<0.05). Basement membrane and extracellular matrix (ECM) proteins were significantly decreased in both AMR compartments. Glomerular and tubulointerstitial laminin subunit γ-1 (LAMC1) expression decreased in AMR, as did glomerular nephrin (NPHS1) and receptor-type tyrosine-phosphatase O (PTPRO). The proteomic analysis revealed upregulated galectin-1, which is an immunomodulatory protein linked to the ECM, in AMR glomeruli. Anti-HLA class I antibodies significantly increased cathepsin-V (CTSV) expression and galectin-1 expression and secretion in human glomerular endothelial cells. CTSV had been predicted to cleave ECM proteins in the AMR glomeruli. Glutathione S-transferase ω-1, an ECM-modifying enzyme, was significantly increased in the AMR tubulointerstitium and in TNFα-treated proximal tubular epithelial cells. CONCLUSIONS: Basement membranes are often remodeled in chronic AMR. Proteomic analysis performed on laser-captured and microdissected glomeruli and tubulointerstitium identified early ECM remodeling, which may represent a new therapeutic opportunity.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Clotet-Freixas S, McEvoy CM, Batruch I, et al. Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study. J Am Soc Nephrol. 2020. PMID: 32900843. doi:10.1681/ASN.2020030286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。